Federal regulators created fresh confusion around a controversial subset of wound care products during a 10-day period in which they issued and then withdrew new Medicare coverage guidance.
On September 3, 2025, the U.S. Department of Health and Human Services Office of Inspector General (HHS-OIG) released a report highlighting explosive growth in Medicare Part B spending on skin ...
Decision ensures continued patient access to VENDAJE® and VENDAJE AC® POMPANO BEACH, Fla., Jan. 07, 2026 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC: BSEM), a leading MedTech company focused ...
Severe burn patients have a brighter future thanks to a "new generation" of skin substitutes, suggests a new study. Horrific burn injuries remain one of the most challenging injuries to treat, causing ...
A new report by the Health and Human Services Office of the Inspector General (OIG) analyzes Medicare Part B spending trends for skin substitute products and reveals that expenditures in ...
PHOENIX, Oct. 2, 2024 /PRNewswire/ -- BioLab Holdings, Inc.'s skin substitute brand, BioLab Sciences, a Phoenix-based medical manufacturer specializing in wound healing and wound care products, ...
President Trump’s Freeze Order Applies to Skin Substitute LCDs – LCDs will not be effective until at least April 13, 2025 The MASS Coalition applauds President Trump for his bold action ordering a ...
MIAMI, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Vivex Biologics, Inc., a leading medical technology company, developing and delivering innovative allografts for musculoskeletal and wound-care applications, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback